Novartis will introduce the world’s most expensive medicine to the market
AveXis, a company belonging to the Swiss concern Novartis, announced on Friday that it had received the FDA’s approval for…
refundacja lekow
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.